fluconazole has been researched along with Bright Disease in 1 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
Bright Disease: A historical classification which is no longer used. It described acute glomerulonephritis, acute nephritic syndrome, or acute nephritis. Named for Richard Bright.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kon, Y | 1 |
| Bohgaki, M | 1 |
| Notoya, A | 1 |
| Mukai, M | 1 |
| Kohno, M | 1 |
| Sato, H | 1 |
1 other study available for fluconazole and Bright Disease
| Article | Year |
|---|---|
Microscopic polyangitis triggered by fungal infection.
Topics: Antibodies, Antineutrophil Cytoplasmic; Antifungal Agents; Candidiasis; Fluconazole; Glomerulonephri | 2006 |